Synlogic, Inc. (SYBX) Stock Price & Analysis
Synlogic, Inc. (SYBX) fell 4.10% to USD 1.17 as of September 8, 2026 at 07:36 UTC, according to Nexqual real-time market data.
SYBX last closed at USD 1.17; the session ranged USD 1.13–1.22 on volume of 478 shares. Market capitalization is —, with a 52-week range of USD 0.54–1.87 (PNK). Source: Nexqual, September 8, 2026 at 07:36 UTC.
Key Statistics (as of September 8, 2026 at 07:36 UTC)
| Price | USD 1.17 |
|---|---|
| Change | ▼ 4.10% (down) |
| Previous Close | USD 1.17 |
| Open | USD 1.17 |
| Day Range | USD 1.13 – 1.22 |
| 52-Week Range | USD 0.54 – 1.87 |
| Volume | 478 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (SYBX)
Nexqual's technical model rates SYBX "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 07:36 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 62.18 (neutral) |
| vs SMA50 | Above (USD 0.98) |
| MACD | 0.06 (positive) |
From Synlogic, Inc.'s Latest SEC 10-K Filing (filed 2026-03-12)
Key Strengths & Strategy (as disclosed to the SEC)
- We seek to protect our proprietary technology and processes, in part, by entering into confidentiality agreements with our employees, consultants, collaborators, advisors, independent contractors or other third parties.
- Our success depends in part on our ability to develop, manufacture, market and sell our product candidates and use our proprietary technology without infringing the patent rights of third parties.
- The legal systems of some countries, particularly some developing countries, do not favor the enforcement of patents, trade secrets, and other intellectual property protection, particularly those relating to biopharmaceutical products, which could make it difficult in those jurisdictions for us to stop the infringement or misappropriation of our patents or other intellectual property rights, or the marketing of competing products in violation of our proprietary rights.
- As we outsource more of our information systems to vendors, engage in more electronic transactions with payors and patients, and rely more on cloud-based information systems, the related security risks will increase and we will need to expend additional resources to protect our technology and information systems.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EVLO | Evelo Biosciences, Inc. | USD 0 | ▲ 0% |
| ASMB | Assembly Biosciences, Inc. | USD 36.6 | ▼ 0.33% |
| MRKR | Marker Therapeutics, Inc. | USD 1.18 | ▼ 5.6% |
| CYPH | Cypherpunk Technologies Inc. | USD 2.42 | ▲ 44.05% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:36 UTC. This page is informational and not investment advice.